Takuya Matsuda

Takuya Matsuda

Auto-generated profile, based on publicly available information

Takuya Matsuda

Osaka City Gen Hosp, Dept Crit Care Med, Osaka, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
NTNoriko Takata
Noriko Takata
MMMasao Miyagawa
Masao Miyagawa
TMTakuya Matsuda
Takuya Matsuda
MTMasahiro Takakado
Masahiro Takakado
TOTomohisa Okada
Tomohisa Okada
TKTeruhito Kido
Teruhito Kido

18 August 2023 in Modern Rheumatology Case Reports
Verified
Journal Article
Closed access
PDF file
TMTakuya Matsuda
Takuya Matsuda
THTaiki Haga
Taiki Haga
TSTakaaki Sakaguchi
Takaaki Sakaguchi
TKToshiaki Kan
Toshiaki Kan
YOYasunori Otsuka
Yasunori Otsuka
Autoimmune diseases, including dermatomyositis, can be complicated by an acquired autoimmune coagulation factor XIII deficiency, which sometimes results in fatal bleeding. Here, we report the case of a young woman with anti-NPX-2 antibody-positive dermatomyositis who developed massive haemothorax with acquired factor XIII deficiency during treatment, including plasma exchange therapy. Emergency transcatheter arterial embolisation was performed and coagulation factor XIII concentrates (Fibrogammin P® 240 U/day for 5 days) were supplemented. Subsequently, the patient was discharged and managed with oral prednisolone and tacrolimus. Coagulation system test results were followed up regularly and remained within normal limits and the patient progressed without recurrence of bleeding symptoms. Coagulation factor XIII deficiency cannot be assessed without measuring coagulation factor XIII activity because common coagulation-fibrinolytic system test results are not abnormal. The measurement of factor XIII activity should be performed when autoimmune diseases are complicated by unexplained bleeding.